Design Therapeutics (DSGN) Operating Margin (2020)
Design Therapeutics' Operating Margin history spans 1 years, with the latest figure at 11700.0% for Q4 2020.
- For Q4 2020, Operating Margin changed N/A year-over-year to 11700.0%; the TTM value through Sep 2021 reached 86560.61%, changed N/A, while the annual FY2025 figure was 821.36%, 33381.0% down from the prior year.
- Operating Margin for Q4 2020 was 11700.0% at Design Therapeutics, up from 11915.0% in the prior quarter.
- Across five years, Operating Margin topped out at 438.73% in Q1 2020 and bottomed at 11915.0% in Q3 2020.